4 Post-treatment control or treated controllers? The impact of ART on time to viral rebound in recent seroconverters
G.E. Martin,
M. Gossez,
J.P. Williams,
W. Stöhr,
J. Meyerowitz,
E.M. Leitman,
G. Ramjee,
K. Porter,
S. Fidler,
J. Frater
Affiliations
G.E. Martin
University of Oxford, Nuffield Department of Medicine, Oxford, United Kingdom
M. Gossez
University of Oxford, Nuffield Department of Medicine, Oxford, United Kingdom
J.P. Williams
University of Oxford, Nuffield Department of Medicine, Oxford, United Kingdom
W. Stöhr
University College London, Medical Research Council, Clinical Trails Unit, London, United Kingdom
J. Meyerowitz
University of Oxford, Nuffield Department of Medicine, Oxford, United Kingdom
E.M. Leitman
University of Oxford, Department of Paediatrics, Oxford, United Kingdom
G. Ramjee
Medical Research Council HIV Prevention Research Unit, Durban, South Africa
K. Porter
University College London, Medical Research Council, Clinical Trails Unit, London, United Kingdom
S. Fidler
Imperial College London, Division of Medicine, Wright Fleming Institute, London, United Kingdom
J. Frater
University of Oxford, Nuffield Department of Medicine, Oxford, United Kingdom; Institute for Emerging Infections, Oxford Martin School, Oxford, United Kingdom; Oxford National Institute of Health Research Biomedical Research Centre, Oxford, United Kingdom
